SEC Form 4 · accession 0001179110-16-020731
ABBOTT LABORATORIES · ABT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian B Yoor
Officer — Senior Vice President and CFO
Period of report
Feb 29, 2016
Accepted (ET)
Mar 2, 2016 · 7:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000001800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common shares without par value | Feb 29, 2016 | F | 1,840 | $39.52 | D | 52,250 | D | |
| Common shares without par value | Feb 29, 2016 | S | 165 | $39.1223 | D | 52,085 | D | |
| Common shares without par value | Feb 29, 2016 | S | 700 | $39.125 | D | 51,385 | D | |
| Common shares without par valueF1 | holding | — | — | — | 2,078 | I | Profit Sharing Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Balance in the Abbott Laboratories Stock Retirement Trust as of February 29, 2016.
Remarks
The sale transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).